Autism Speaks

The consortium is collecting data from different omics streams for a cohort of individuals with autism spectrum disorders with the long-term goal of improving treatment.

BioTeam has developed a web portal for the MSSNG repository that offers easy access to genomic, phenotype, and clinical data collected through the project.

David Glazer from Google Genomics provided an update on the MSSNG project, a collaboration between Autism Speaks, The Hospital for Sick Children in Toronto, and Google.

Genome sequences generated for the Autism Speaks MSSNG project provided evidence of genetic heterogeneity in 85 families, each containing two children affected by autism spectrum disorder.

NEW YORK (GenomeWeb) – Autism Speaks said today it will collaborate with Google to create a database of genomic information on autism spectrum disorder that will be an open resource for use by autism researchers and will be available via the Google Cloud Platform.

NEW YORK (GenomeWeb News) – Autism Speaks yesterday announced nine new winners of its Dennis Weatherstone Predoctoral Fellows grants, including three researchers studying some of the possible genetic and epigenetic factors involved in autism.

NEW YORK (GenomeWeb News) – Autism Speaks today announced a $3 million gift in support of its Autism Ten Thousand Genomes program (Aut10K) to sequence the world's largest collection of whole genomes of individuals with autism spectrum disorder and their families.

NEW YORK (GenomeWeb News) – Autism Speaks said today that its nonprofit affiliate Delivering Scientific Innovation for Autism (DELSIA) will provide $2 million for a biomarker discovery project with Seaside Therapeutics, a drug developer that plans to market a new personalized treatment.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.